Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$822.3M
Avg Funding
$32.9M
Global Reach
7
countries

Top Cities for Biopharma

Palo Alto
Oxford
Scotland
Sheffield
Geneva
San Diego

Recently Funded Companies

Export
Palo Alto, United States

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.

$200.0M raised
May 2024

Founder Contacts

30,000+ verified contacts

Oxford, United Kingdom

Accession Therapeutics is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumor diversity.

$31.3M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

Scotland, United States

Glen Clova Scientific is a company that developing a new gneration of active biological drugs.

$5.0M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

Sheffield, United Kingdom

Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics.

$202K raised
Apr 2024

Founder Contacts

30,000+ verified contacts

Geneva, Switzerland

Neurosterix is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.

$63.0M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

San Diego, United States

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

$132.0M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

San Leandro, United States

Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.

$11.4M raised
Mar 2024

Founder Contacts

30,000+ verified contacts

Austin, United States

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

$220K raised
Mar 2024

Founder Contacts

30,000+ verified contacts

South Burlington, United States

Kria Botanicals is a wholesale producer of full-spectrum, organically grown CBD oil and terpenes.

$1.1M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

The Woodlands, United States

Othram aims to revolutionize how forensic cases are solved, justice is served, and families are mended.

$6.6M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Brooklyn, United States

Caladan Bio specializes in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions.

$5.1M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

$56.0M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Stevenage, United Kingdom

Genevation LTD is a pre-clinical stage biotechnology company specializing in the development of Personalised Cancer vaccines.

$505K raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Innsbruck, Austria

Supporting pharmaceutical companies to meet the highest standards in quality and efficiency with data-driven solutions.

$6.2M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

New York, United States

LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.

$75.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Fujisawa, Japan

Prism is a biotechnology company that develops therapeutic drugs that cure intractable diseases using unique peptide mimic technology.

$10.2M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Emeryville, United States

Reservoir Neuroscience is a biopharma company that develops novel therapeutics.

$4.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Concord, United States

Our purpose is to make every pregnancy around the world safer.

$75.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Boston, United States

Ratio Therapeutics is a clinical phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.

$50.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

San Diego, United States

Vasa Therapeutics is a privately held, preclinical-stage encinitas, CA-based biopharmaceutical company.

$6.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Magdeburg, Germany

Making high-value glycans mainstream

$1.8M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries

$7.0M raised
Dec 2023

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.

$66.0M raised
Dec 2023

Founder Contacts

30,000+ verified contacts

Singapore, Singapore

Meatiply is a food research company that develops and produces meat alternatives through cell cultivation.

$3.8M raised
Dec 2023

Founder Contacts

30,000+ verified contacts

Philadelphia, United States

Philadelphia-based biotechnology company .

$5.1M raised
Dec 2023

Founder Contacts

30,000+ verified contacts

Showing 551 to 575 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$32.9M
Total Funding Tracked
$822.3M
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.San Diego
2 companies$138.0M
2.Cambridge
2 companies$73.0M
3.Palo Alto
1 companies$200.0M
4.Oxford
1 companies$31.3M
5.Scotland
1 companies$5.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

854 Biopharma Startups (2026) — Recently Funded Companies, Investors & Rounds — Page 23 | VCBacked